5 Easy Facts About Crizotinib Described
Risdiplam is the sole orally administered drug approved for that treatment method of SMA. It had been FDA authorized in 2020 to be used in individuals two months of age and more mature, and it capabilities as an SMN2 gene splicing modifier bringing about better levels of SMN protein. Oral administration is an important benefit of this drug because